Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
BAX COV BDX BCR Consumption Oil And Gas Moderate Semiconductor 
United States GSPC USD ...  |  Screen Global Equities


Processing
Collecting data for BDX

Becton quote and profile

 
 Companies |  Insiders  | Dashboard  
     
101.01
  
STOCK
(0.11)  Macroaxis: -0.11 Down   0.11%  
Year To Date
71.56102
Last 1 Month(s)
93.58102
Trading Day 
101102
May 21 2013 

Diversification Suggestion

Use Becton to protect against small markets fluctuations. The stock experiences normal downward trend and little activity
Analyze Becton Dickinson and Trend or Check current 30 days Becton correlation with market (S&P 500)
1 Month Beta 1.39  
Highest Price:  
Lowest Price:  
101.78  
93.58  
May 17 2013 
May 01 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Becton will likely underperform.
Becton Dickinson and Company Large BetaBecton Dickinson and Beta Legend
BDX United States NYSE
Becton Dickinson and Company
Healthcare
Medical Instruments and Supplies
Benchmark S&P 500
http://www.bd.com
Contact Number: 201. 847. 6800
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation20 B
Shares Outstanding193.96 M
Number of Shares Shorted8.34 M
Revenue7.78 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 United States NYSE   0.11 % Macroaxis: 0.11 Moved Up  
 
 United States Russel   0.08 % Macroaxis: 0.08 Moved Up  
 
 thisRed BDX BDX agains markets  0.11 % Macroaxis: 0.11 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Becton Leadership

Vincent BD Chairman, CEO and Pres
Henry Becton Lead Director, Chairman of Corporate Governance and Nominating Committee, Member of Executive Committee and Member of Science, Innovation and Technology Committee
Vincent Forlenza Chairman of the Board and Presidentident, CEO, MBA
MHS MD Independent Director, Chairman of Science, Innovation and Technology Committee, Member of Executive Committee and Member of Corporate Governance and Nominating Committee

Becton Price and Market Media

The median price of Becton for the period between Sun, Apr 21, 2013 and Tue, May 21, 2013 is 97.43 with a coefficient of variation of 2.76. The daily time series for the period is distributed with a sample standard deviation of 2.69, arithmetic mean of 97.59, and mean deviation of 2.24. The Stock received substential amount of media coverage during this period.
Becton         SP 500
Price Growth (%)
 
1
BECTON DICKINSON AND CO. FDA Approves Second Drug in BD Simp...04/24/2013Macroaxis: News
2
Becton Dickinson reports net income down in 2nd quarter05/03/2013Macroaxis: News
3
Reiterate Becton Dickinson at Neutral Analyst Blog NASDAQ.co...05/08/2013Macroaxis: News
4
Becton Dickinson and Co. Novo Nordisk AS Does The ...05/15/2013Macroaxis: News
5
Becton Dickinson quotBuyquot Rating Reaffirmed at CL King05/17/2013Macroaxis: News

Becton Summary

Becton Dickinson and Company [BDX] is traded on New York Stock Exchange in USA. It is located in Becton, Dickinson and CompanyFranklin Lakes, NJ and employs 29,555 people. The company currently falls under 'Large-Cap' category with total capitalization of 18.34 B. Becton Dickinson and Company runs under Healthcare sector within Medical Instruments and Supplies industry. This company has 193.96 M outstanding shares of which 8.34 M shares are currently shorted by investors with about 7.7 days to cover shorted positions.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. more
Past Market
Over 30
Days
14
Out Of
100
 
Chance of
Less
Than
35 %
 
Follow Becton with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Becton to your reader
 

Becton Research Report

Becton vs. Baxter

Correlation analysis and fundamentals comparison between Becton Dickinson and and Baxter International

Becton Executives

David Elkins CFO and Executive VP
William Kozy COO and Executive VP

Becton Directors

Claire Fraser-Liggett Independent Director, Ph.D
Marshall Larsen Independent Director
Rebecca Rimel Director, MBA
Christopher Jones Independent Director
Willard Overlock Independent Director

Becton Fundamentals

Number of Shares Shorted vs Number of Employees
Cash per Share vs Return On Equity
Number of Shares Shorted vs Price to Earnings To Growth
Return On Asset vs Return On Equity

Becton vs Competition

Becton vs. Baxter International Inc
Becton vs. Covidien plc
Becton vs. CR Bard Inc
Becton vs. CareFusion Corporation
Becton vs. DENTSPLY International Inc
Becton vs. The Cooper Companies Inc
Becton vs. Mindray Medical International Limited
Becton vs. Teleflex Incorporated
Becton vs. West Pharmaceutical Services Inc

Becton May 21 2013 Opportunity Range

Downside Deviation0.9753
Information Ratio(0.01)
Maximum Drawdown3.59
Value At Risk(0.92)
Potential Upside1.9

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium